LIPID-LOWERING DRUG THERAPY

Course overview

PATIENTS AT AN INCREASED RISK OF CARDIOVASCULAR EVENTS (CARDIOVASCULAR DEATH, NONFATAL MI, NONFATAL STROKE, CORONARY REVASCULARIZATION, OR UNSTABLE ANGINA) BENEFIT FROM LIPID-LOWERING MEDICATIONS. IT IS ESSENTIAL TO RECOGNIZE THAT THESE DRUGS ARE USEFUL IN COMBINATION WITH LIFESTYLE MODIFICATION. THESE MEDICATIONS CAN BE USED FOR PRIMARY OR SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS. THIS ACTIVITY COVERS LIPID-LOWERING PHARMACEUTICAL INTERVENTIONS THAT MEMBERS OF THE INTERPROFESSIONAL TEAM NEED TO REVIEW THE INDICATIONS, CONTRAINDICATIONS, AND ADVERSE EVENT PROFILES TO OPTIMALLY MANAGE PATIENTS WITH ABNORMAL LIPID PROFILES AND DIRECT CARE TO OPTIMAL OUTCOMES.